You are here

Sun Mon Tue Wed Thu Fri Sat
 
 
1
 
2
 
3
 
4
 
5
 
6
 
7
 
8
 
9
 
10
 
11
 
12
 
13
 
14
 
15
 
16
 
17
 
18
 
19
 
20
 
21
 
22
 
23
 
24
 
25
 
26
 
27
 
28
 
 
 
 
 
 

Event Types

CIIID Quarterly Seminar (Winter)

Event Date: 
Tuesday, January 24, 2017 - 10:00am

Speaker:  Steve Polyak, Ph.D., Research Professor, Department of Laboratory Medicine; Graduate Program Director, Laboratory Medicine; Adjunct Research Professor, Departments of Global Health and Microbiology; UW Affiliate Investigator, VIDD, FHCRC;  CIIID Member

Seminar Title: "Deciphering how drugs from nature suppress cellular inflammatory status"

PDF iconSeminar flyer

CIIID Quartertly Seminar (Spring)

Event Date: 
Tuesday, May 2, 2017 - 10:00am

Invited Speaker:  Klaus Schughart, Ph.D., Professor, Head of Dept. of Infection Genetics Helmholtz Centre for Infection Research, University of Veterinary Medicine Hannover, University of Tennessee Health Science Center

Talk Title: “Host-pathogen interactions during influenza A virus infection”

PDF iconSeminar Flyer

 

CIIID Quarterly Seminar (Summer)

Event Date: 
Tuesday, August 1, 2017 - 10:00am

Invited SpeakerAleem Siddiqui, Professor, Department of Medicine, University of California, San Diego

Talk Title: “Mitochondrial dynamics and innate immunity in viral hepatitis B and C”

 PDF iconSeminar flyer in PDF

Special CIIID Seminars

Event Date: 
Thursday, March 8, 2018 - 1:00pm

TALK TITLE: "Machine Learning for Life Sciences - Understanding viral pathogenesis and vaccine protection"

SPEAKERS:
Jan Komorowski, Ph.D., Chaired Professor of Bioinformatics, Uppsala University, Sweden.
Carl Fredrik Barrenäs, Ph.D., Researcher, Uppsala University, Sweden.

Event flyer

CERID/CIIID seminar

Event Date: 
Friday, March 23, 2018 - 12:00pm

Lecture presented by Dr. Kristina Adams Waldorf on Zika work

Special CIIID Seminars

Event Date: 
Monday, May 14, 2018 - 10:00am

Presenter:  Shin-Ru Shih, Ph.D., Director/Professor, Research Center for Emerging Viral Infections, Chang Gung University, Taiwan.

  • Dr. Shih and her team have been studying various aspects of emerging RNA viruses, including identification of viral pathogens during outbreaks, mechanistic studies of pathogenesis, and development of vaccines and antiviral agents. RNA viruses are their major focuses. Their study of enterovirus A71 (EV-A71) began in 1998, when a large EV-A71 outbreak occurred in Taiwan.
  • Talk Title:  "Viral and host factors involved in enterovirus infection – potential applications in therapy and prophylaxis"

Presenter:  Rei-Lin Kuo, Ph.D., Associate professor, Research Center for Emerging Viral Infections & Department of Medical Biotechnology and Laboratory Science, Chang Gung University, Taiwan

  • Dr. Kuo's research in enterovirus 71 (EV71) was initiated during the graduate study for investigating the molecular mechanism of pathogenesis of EV71 infection.

  • Talk Title:  "Dysregulation of type I interferon response during EV71 infection"

Printable flyer click here.

CIIID Fall Quarter Seminar: Michael Gantier, Ph.D.

Event Date: 
Friday, September 28, 2018 - 10:00am

PresenterMichael P. Gantier, Ph.D., ARC Future Fellow and Group Leader, Centre for Innate Immunity and Infectious Diseases, Hudson Institute of Medical Research (Australia)

Talk Title"When nucleic acids sensing turns toxic: novel strategies to control auto-inflammation"

"Our laboratory recently discovered that mild DNA damage originating from DNA intercalation or gene recombination could lead to the leakage of nuclear DNA into the cytoplasm, resulting in the activation of the immune sensor cGAS and downstream production of pro-inflammatory cytokine such as type-I interferons (Pepin et al., Nucleic Acids Research, 2016 and 2017; Pepin et al. mBio 2017). Independent studies validated our findings and are collectively showing that cGAS sensing of leaked cytosolic DNA acts as a critical checkpoint of genomic integrity, and stops cell proliferation of damaged cells to maintain tissue homeostasis. Here I will present some of our latest research investigating how cGAS engagement in damaged cells modulates tissue homeostasis and inflammation, and why this could present novel therapeutic opportunities in auto-inflammatory diseases such as systemic lupus erythematosus (SLE). I will also introduce our on-going studies on the rational design of next generation immuno-modulatory oligonucleotides and define why such molecules present exciting potential for the modulation of toxic nucleic acids sensing, for instance seen in SLE."

Event Flyer click here